QuickView for PNU-282987 (compound)

No studies found

1. PNU-282987 Attenuates Intestinal Epithelial Barrier Dysfunction in LPS-Induced Endotoxemia.
2. Effect of Intrahippocampal Administration of α7 Subtype Nicotinic Receptor Agonist PNU-282987 and It…
3. A Selective α7 Nicotinic Acetylcholine Receptor Agonist, PNU-282987, Attenuates ILC2s Activation and…
4. Effects of VAChT reduction and α7nAChR stimulation by PNU-282987 in lung inflammation in a model of …
5. Activation of α7 nAChR by PNU-282987 improves synaptic and cognitive functions through restoring the…

There were no clinical trials for PNU-282987